RituximAPP™ app for iPhone and iPad

Swiss RituximAPP™
Official App of Roche Pharma (Schweiz) AG

The Swiss RituximAPP™
- was developed together with Swiss lymphoma experts and tested and approved by Prof. Dr. Stephan Dirnhofer, Basel, and PD Dr. Christoph Mamot, Aarau.

- is for health care professionals only and, as required by law, can only be used after a password check. The password will only be available for healthcare professionals. Please contact us at at swiss.rituximapp@roche.com or ask your local Roche delegate.

- offers information, references, calculation & support tools to assess lymphoma patients in your daily clinical practice.

- allows you to send customized treatment schedules in PDF-format to yourself. For these purposes, information will be routed from your mobile device via an automated conversion server to your e-mail account. Please read carefully the Legal Notices contained in the information section of the App.

Please note also that no data or information other than your default e-mail address, which is required for safety reasons, will be transferred or stored by or for Roche.


The Swiss RituximAPP™ features:

A: Check WHO-Classification of Lymphomas
Inform yourself about epidemiology, biomarkers, ICD-O and intensity and frequency of CD20 in all lymphomas of the official WHO Classification (2008):

- 31 Mature B-Cell neoplasms
- 21 Mature T-Cell and NK-cell neoplasms
- 7 Immunodeficiency-associated lymphoproliferative disorders
- 2 types and 4 subtypes of Hodgkin Lymphoma

B: Caclulate Staging Systems
Calculate the most frequently used staging systems in the clinical setting of haematology:

- Ann Arbor
- Binet (CLL)
- Rai (CLL)
- ISS (MM)
- Durie & Salmon (MM)

C: Assess Prognostic Indices
Assess the most frequently used prognostic indices in the clinical setting of haematology:

- IPI (aggressive Lymphoma)
- FLIPI (FL)
- FLIPI 2 (FL)
- MIPI (MCL)
- IPS (HD)

D: Evaluate Performance Indices
Evaluate the fitness of your patients with frequently used performance indices:

- ECOG Performance status
- CIRS Score for CLL

E: Miscellaneous functions
Calculate several helpful features

- Body Surface Calculator
- Creatinine Clearance
- Active Disease in CLL
- Direct link to the used online references / e-papers

F: Cacluate dates & dosages of Administration Schedules

Predefined Rituximab Schedules: the following treatment schedules are ready for use:

- PRIMA: R-CHOP/CVP & 12 x R
- EORTC 20981: R-CHOP & 8 x R
- SAKK 35 /98: 4 x R & 4 x R
- GELA LNH.98.5: R-CHOP-21
- RiCOVER-60: R-CHOP-14 + 2 R
- CLL8 / REACH: 6 x R-FC


Own administration schedules: Calculate dates & dosages of your own administration schedules in 3 steps, the App includes the following compounds:

- Alemtuzumab
- Bendamustine
- Bortezomib
- Carboplatin
- Chlorambucil
- Cisplatin
- Cladribine
- Cyclophosphamide
- Cytarabine
- Dexamethasone
- Doxorubicin
- Etoposide
- Fludarabine
- Gemcitabine
- Ifosfamide
- Lenalidomide
- Melphalan
- Mitoxantrone
- Prednisone
- Rituximab
- Thalidomide
- Temsirolimus
- Vincristine
- Vinorelbine